Evidence map›Paper›PMID 34950852›Full record

ArticleProgress in biomedical engineering (Bristol, England)2022

Protein Based Biomaterials for Therapeutic and Diagnostic Applications.

Stanley Chu, Andrew L Wang, Aparajita Bhattacharya, Jin Kim Montclare

Abstract read
In one paragraph

Article in Progress in biomedical engineering (Bristol, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Design and Heterologous Production of Bagworm Silk-Inspired Proteins inComputational and structural biotechnology journal · 2026
    Article
  4. Article
  5. Article
  6. Biohybrid Computing with Proteinoids and Algae.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Stanley ChuDepartment of Chemical and Biomolecular Engineering, NYU Tandon School of Engineering, Brooklyn, NY, United States of America.
Andrew L WangDepartment of Chemical and Biomolecular Engineering, NYU Tandon School of Engineering, Brooklyn, NY, United States of America.
Aparajita BhattacharyaDepartment of Chemical and Biomolecular Engineering, NYU Tandon School of Engineering, Brooklyn, NY, United States of America.
Jin Kim MontclareDepartment of Chemical and Biomolecular Engineering, NYU Tandon School of Engineering, Brooklyn, NY, United States of America.ORCID 0000-0001-6857-3591

Funding

NRSA Training CoreTL1TR001447 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MICOLI, KEITH J. · 2015 to 2025
$5.9M
Computationally Designed Stable Artificial Phosphotriesterases for Detoxification of Organophosphorus AgentsR21NS103831 · NINDS · NEW YORK UNIVERSITY · PI MONTCLARE, JIN KIM · 2017 to 2018
$349k
NCATS NIH HHS TL1 TR001447NINDS NIH HHS R21 NS103831
6 · The paper itself

Abstract

Proteins are some of the most versatile and studied macromolecules with extensive biomedical applications. The natural and biological origin of proteins offer such materials several advantages over their synthetic counterparts, such as innate bioactivity, recognition by cells and reduced immunogenic potential. Furthermore, proteins can be easily functionalized by altering their primary amino acid sequence and can often be further self-assembled into higher order structures either spontaneously or under specific environmental conditions. This review will feature the recent advances in protein-based biomaterials in the delivery of therapeutic cargo such as small molecules, genetic material, proteins, and cells. First, we will discuss the ways in which secondary structural motifs, the building blocks of more complex proteins, have unique properties that enable them to be useful for therapeutic delivery. Next, supramolecular assemblies, such as fibers, nanoparticles, and hydrogels, made from these building blocks that are engineered to behave in a cohesive manner, are discussed. Finally, we will cover additional modifications to protein materials that impart environmental responsiveness to materials. This includes the emerging field of protein molecular robots, and relatedly, protein-based theranostic materials that combine therapeutic potential with modern imaging modalities, including near-infrared fluorescence spectroscopy (NIRF), single-photo emission computed tomography/computed tomography (SPECT/CT), positron emission tomography (PET), magnetic resonance imaging (MRI), and ultrasound/photoacoustic imaging (US/PAI).

Indexed as

Biomaterialsdrug deliveryproteinself-assembly

Identifiers

PMID34950852
PMCPMC8691744

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.